Therapies Offered at Residential Addiction Treatment Programs in the United States
- PMID: 32840587
- PMCID: PMC7448823
- DOI: 10.1001/jama.2020.8969
Therapies Offered at Residential Addiction Treatment Programs in the United States
Abstract
This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.
Conflict of interest statement
References
-
- Substance Abuse and Mental Health Services Administration Behavioral Health Spending & Use Accounts, 2006-2015 Published February 2019. Accessed October 30, 2019. https://store.samhsa.gov/product/Behavioral-Health-Spending-and-Use-Acco...
-
- Christie C, Baker C, Cooper R, Kennedy PJ, Madras B, Bondi P. The President’s Commission on Combating Drug Addiction and the Opioid Crisis: Final Report Published November 1, 2017. Accessed July 9, 2020. https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Final_Repor...
-
- Substance Abuse and Mental Health Services Administration National Survey of Substance Abuse Treatment Services (N-SSATS): 2018 Published September 2019. Accessed October 30, 2019. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSSATS-201...
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
